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Objective: To determine the frequency of vaginal vault recurrences in comparison with other port site
recurrences following unplanned laparoscopic surgical treatment for gynecological malignancies.
Design: Retrospective analysis of a prospectively maintained database of eight patients who underwent
laparoscopic procedures for different gynecological malignancies.
Results: Eight patients were identiﬁed to have port site recurrences. Out of these, seven had undergone
laparoscopic surgery for ovarian tumor andwere reported to bemalignantwith the exception of onewhich
was a borderline ovarian tumor. One case had a ﬁbroid uterus, which later turned out to be a leiomyo-
sarcoma. Vaginal vault recurrence was seen in four out of the eight cases, and only one patient could be
saved.Whereas out of the four cases with other port recurrences, three patients are in complete remission.
Conclusion: Apart from other port recurrences, vaginal vault is a potential site of recurrence. But it is
more signiﬁcant as it results in greater morbidity and carries a worse prognosis than other port
recurrences.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Port site metastasis is a well-known phenomenon following
laparoscopic surgeries for abdominal malignancies. Gynecological
malignancies are not an exception to this. Apart from other port
recurrences, vaginal vault is a potential site of recurrence. But it is
more signiﬁcant as it results in greater morbidity and carries a
worse prognosis than other port recurrences.
The objective of this study was to determine the frequency and
outcome of vaginal vault recurrences in comparisonwith other port
site recurrences following unplanned laparoscopic surgical treat-
ment for gynecological malignancies.
Materials and methods
The study is a retrospective analysis of a prospectively main-
tained database of all the patients who were referred to us. A totalof interest relevant to this
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r PO, Kochi 682040, Kerala,
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rGynecologicEndoscopyandMinimal
nc-nd/4.0/).of eight patients were identiﬁed from May 2006 to August 2009
with port site metastasis following laparoscopic procedures of
varying magnitudes for gynecological malignancies.They were
followed-up to date.
This study was conducted in the Department of Surgical and
Gynecological Oncology at Lakeshore Hospital and Research Centre
in Cochin, India which is a tertiary care center and a leading
oncology center in a private set-up. A detailed note of referral
documents of patients referred to us was made, followed by thor-
ough clinical examination, radiological reassessment, and tumor
marker levels wherever applicable. Histopathological reports were
reviewed. Conditions of the patients were optimized and subse-
quently taken for exploration.Results
Out of the eight patients, seven patients had undergone lapa-
roscopic surgery for ovarian tumors, and one for ﬁbroid uterus.
None of these were performed by a gynecological oncologist.
Vaginal vault recurrence was seen in four out of the eight cases. In
all these cases, specimens were retrieved through the vagina. No
endobags were used in any of these cases. One patient had exten-
sive disease in the abdominal port and contiguous abdominal andly InvasiveTherapy. PublishedbyElsevier TaiwanLLC. This is anopenaccessarticleunder theCC
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ports. In two cases it was at the port of the ovariotomy specimen
removal, and one at the biopsy removal port.
Seven had ovarian malignancy, six cases of serous cyst adeno-
carcinoma, and one case of borderline ovarian tumor. The eighth
casewhichwas diagnosed as a case of leiomyoma turned out to be a
leiomyosarcoma at histopathological examination.
The most common mode of presentation of recurrence was
bleeding per vaginum. The time duration for recurrence was be-
tween 2 weeks and 1 year. Out of the eight patients, four patients
underwent laparotomy and cytoreduction. One patient was inop-
erable. Two patients were given neoadjuvant chemotherapy before
surgery. The leiomyosarcoma case received radiotherapy followed
by second line chemotherapy.
Out of the four vaginal vault recurrences only one patient could
be salvaged. Luckily she did not have any nodal or extra pelvic
disease. She is now disease free at 5 years. In spite of extensive
surgery and adjuvant treatment two patients died of progressive
disease and one case had an inoperable disease.
One patient with abdominal port recurrence also had an inop-
erable disease (Case 4). Three patients (Case 1, Case 2, and Case 3)
are alive after deﬁnitive surgeries.
Brief case summary
First case
The patient underwent laparoscopy for bilateral ovarian tumor.
She was found to be inoperable then, and deﬁnitive surgery was
abandoned. Only a biopsy was taken. She was referred to us with
the biopsy report of papillary serous cysatadenocarcinoma. But on
examination the mass was found to be mobile and felt operable.
She was taken for laparotomy after complete evaluation. Staging
laparotomy was done along with excision of the right iliac fossa
port which was studded with metastasis. Postoperatively adjuvant
chemotherapy was given.
Cases 2 and 3
These patients had undergone laparoscopic ovariotomy for
presumably stage 1 disease. The pathological report of one patient
showed a borderline mucinous tumor. After 1 year she presented
with a huge suprapubic port recurrence and was taken for cytore-
ductive surgery. Optimum cytoreduction could be achieved
including excision of the port recurrence. Prolene mesh repair was
performed at the site of port recurrence excision. She was given
adjuvant chemotherapy with paclitaxel and carboplatin since the
histopathology report showed mucinous adenocarcinoma. How-
ever, she was found to have locally progressive disease.
The other patient who had undergone laparoscopic ovariotomy
had a pathological report showing a serous cyst adenocarcinoma
and underwent restaging laparotomy with port excision 1 month
after laparoscopy.
Cases 4 and 5
Both patients had undergone total laparoscopic hysterectomy
with bilateral salpingo oopherectomy for unilateral ovarian tumor.
In one of these patients, part of the tumor was left behind as it was
adherent to bowel serosa. She had received three courses of adju-
vant chemotherapy and was found to have recurrence at the port
site. Hence, she was referred to us for surgery. On examination she
had a left iliac fossamass (port site) with other intra-abdominal and
ﬁxed pelvic masses which were unresectable. Only the port sitecould be excised completely and the pathology report conﬁrmed
recurrence.
The other patient underwent total laparoscopic hysterectomy
with the removal of an ovarian tumor vaginally. She had received
six cycles of adjuvant chemotherapy with paclitaxel and carbo-
platin. After 1 year she presented with severe vaginal and perineal
pain. On examination, a huge vault recurrence was seen causing a
rectovaginal ﬁstula. As it was inoperable, she was given three
courses of chemotherapy. Later she was re-evaluated and was
subsequently taken for surgery with resection of the mass, resec-
tion anastomosis, and covering colostomy. She received three more
cycles of chemotherapy and the colostomy closure was performed
after completion of her treatment.
Cases 6 and 7
These two patients had undergone laparoscopic assisted vaginal
hysterectomy and removal of ovarian tumors vaginally. Histopa-
thology report showed an adenocarcinoma, and adjuvant chemo-
therapy was given. One of these patients presented with bleeding
per vaginum after 6 months of chemotherapy. Examination showed
a huge recurrence at the vault. The mass was inﬁltrating the rectal
wall and extensive nodal disease was present. She underwent
excision of the recurrence and inﬁltrated rectal wall, along with
nodal dissection. She died of progressive disease 1 year later.
The other case, a postmenopausal patient, had undergone
laparoscopic assisted vaginal hysterectomy and removal of an
ovarian tumor vaginally. She had been given three cycles of adju-
vant chemotherapy followed by completion surgery (omentec-
tomty and lymph node dissection). She then received three more
cycles of chemotherapy. Six months later she presented with pro-
fuse bleeding per vaginum. On examination she was found to have a
highly vascular vaginal vault metastasis. The vaginal vault had not
been re-excised during completion surgery. She received palliative
radiotherapy followed by second line chemotherapy. Later she
developed an abdominal recurrence also and succumbed to death
after 2 years.
Case 8
A 44 year old female underwent total laparoscopic hysterectomy
for multiple ﬁbroids and a specimen was removed with morcella-
tion using the morcellator. Histopathology report conﬁrmed leio-
myoma. After 6 months of surgery, she presented with bleeding per
vaginum and on examination a huge vaginal vault recurrence was
seen which was inﬁltrating the bladder. Trucut biopsy from the
mass was taken which showed a high grade lieomyosarcoma. She
was re-evaluated and re-analyzed. She said that she had noticed a
recent sudden increase in the size of the ﬁbroid and told the
laparoscopist this during the initial consultation. The slides of
initial Histopathological examination (HPE) could not be brought
for review. The patient was given chemotherapy with ifosfamide
and adriamycin, and was later taken up for surgery. Partial cys-
tectomy and removal of the tumor was performed followed by
adjuvant radiation. Despite all these, her disease progressed and
she succumbed to death in a year.
Discussion
The current study was a retrospective analysis of a prospectively
maintained database. All the above cases were referred cases. All
these cases were either not worked up properly or were taken up
for laparoscopy with the assumption that they were all benign.
Also, because of the lack of facilities for frozen sections, intra-
operative conversion of laparotomy and completion of staging were
K. Chitrathara et al. / Gynecology and Minimally Invasive Therapy 5 (2016) 116e119118also not done. None of these specimens were retrieved through
endobags. All were retrieved through culdotomy incision.
Ever since the emergence of laparoscopy, there has been a
paradigm shift in the management of almost all abdominal sur-
geries including gynecological surgeries. This is applicable to
oncosurgeries as well. More and more procedures are being carried
out laparoscopically day by day. However, apart from the learning
curve effect of the procedures, inappropriate evaluation, approach,
and technical misadventures have led to a new spectrum of port
site recurrences including vaginal vault recurrence.
Port site recurrence is a well described phenomenon in human
malignancies and was ﬁrst reported in 1978 by D€obr€onte et al.1,2
The author reported implantation of a malignant ovarian cystic
adenoma in penetration sites of the verres needle and trocar.
The incidence of port site recurrence is further compounded by
the fact that it usually leads to recurrence at other sites and such a
concern is well reported in the literature.3,4 Thus port site metas-
tasis is an obstacle for a good long term outcome.
Major concerns in the management of gynecological malig-
nancies by laparoscopy are risk of port site recurrence, accuracy and
adequacy of surgical staging, and risk of tumor rupture leading to
intraperitoneal dissemination of malignant cells especially solid
tumor. Incidence of port site metastasis in patients with ovarian
cancer varies from < 1% to 16% in the literature.5
Raymond et al6 in 1998 deﬁned portsite metastasis as an early
tumor recurrence that develops locally in the abdominal wall,
within the scar tissue of one ormore trocar sites, or an incision after
laparoscopy or thoracoscopy for cancer, and these implantations
are not associated with peritoneal carcinomatosis. Certain theories
have been put forward to explain metastatic developments at
laparoscopic port sites.7 The factors for port site metastasis can be
divided into three categories: (1) tumor related; (2) wound related;
and (3) surgical technique related.
Surgical technique related manipulation is the principal factor
acting in tumor dissemination. Extraction of surgical specimen is
determined by the surgeon.8,9 Morcellation of the specimen in-
creases tumor seedling. The direct dissemination of tumor cells
from contaminated material or extraction with an unclosed bag is
well documented.10 This is inﬂuenced to some extent by the
expertise of the surgeon and the team.8,11
The risk of rupturing the ovarian cyst and spillage of its content
is higher with laparoscopy compared with open surgery. Haver-
ilesky et al12 reported an overall rupture rate of 25% during lapa-
roscopy for adnexal mass. In a study of 1600 adnexal masses
managed laparoscopically, Canil et al13 reported that 10.11% inva-
sive cancers and out of 67.6% borderline tumors were punctured for
diagnostic purpose. The turbulent gas ﬂow during operative lapa-
roscopy may favor embolization of exfoliated malignant cells.14
In our study, four patients had abdominal port site recurrence
and four patients had vaginal vault recurrences. All patients were
documented as stage 1 disease during the initial surgery and
uterine ﬁbroid as benign leiomyoma.
We want to focus on another site of recurrencedvaginal vault.
In our series of patients, a signiﬁcant number of (50%) patients had
vault recurrence and in all these specimens were removed through
the vagina which led to implantation of malignant cells. In vaginal
vault recurrences, all the patients presented with locally advanced
tumors.
Prevention of direct contact of tumors with the port by the use
of endobags has been proven to reduce port recurrence, which
means tumor load at the port is an important factor in recurrences.
So even in vaginal retrieval, tumor removal in the endobag should
be strictly adhered. Early postchemotherapy recurrences portray a
dismal outcome. However, regular vaginal examinations in such
cases may detect early recurrences which might lead to betteroutcomes in such cases. Great caution has to be applied in deciding
laparoscopy for relatively chemoresistant tumors and early disease
where chemotherapy may not be required at all. One has to balance
between life and few more centimeters of incision.
Another concern is the removal of multiple and large ﬁbroids
in pieces which can lead to incorrect pathology by sampling er-
rors. Anupama et al15 reported a case of disseminated peritoneal
recurrence where the patient did not have a history of rapid
growth. All literature regarding this stress the fact that all efforts
must be made to rule out malignancy before going ahead with
key hole or no hole surgery. One of our patients was able to
recognize the sudden growth of the tumor and passed on this
information to the laparoscopist. Even then she was taken up for
laparoscopy, that too was with the use of a morcellator and not
an endobag for specimen retrieval. The policy of cent percent
laparoscopy among some laparoscopists will prove detrimental in
the long run. So great care has to be taken in deciding laparo-
scopic surgery in such cases. Further thorough evaluation if
necessary is with magnetic resonance imaging and/or positron
emission tomography, and the use of endobags would result in a
much more favorable outcome.
Our concern is well documented in world literature. Several
reports of port site metastasis and tumor seedling have been
published. Morice et al16 reported six cases of port site metastasis
after laparoscopic surgery for gynecological cancer. Cormio et al17
reported nine cases of skin metastasis in ovarian cancer. Anu-
pama et al15 reported a case of disseminated peritoneal leiomyo-
sarcoma after laparoscopic myomectomy and morcellation.
In our study four patients had intra-abdominal port site re-
currences and four patients had vaginal vault recurrences. One
patient with laparoscopic hysterectomy with removal of the spec-
imen vaginally for ﬁbroid uterus and three patients with removal of
ovarianmass vaginally had vault recurrence. None of the 10 women
with metastatic ovarian cancer developed such recurrence in a
retrospective study conducted by Kadar.18 He conducted a study to
determine the frequency of port site recurrence following laparo-
scopic surgical treatment of gynecological malignancies metastatic
at the time of surgery. With a total of 25 patients (22) primary
malignancies (cervix 12, ovary 7, endometrium 3, and 2 in recurrent
ovarian cancer), one women with stage 3c ovarian cancer was
disease free at the completion of N-acetyl cysteine following surgery
by a general surgeon was included in the study, she had developed
scalene node metastasis 8 months after deﬁnitive laparoscopic
surgery. Twenty-four women had metastatic disease at the time
of laparoscopic surgery. All women received adjuvant pelvic or
extended ﬁeld radiation, chemotherapy, or both. Four women (16%)
developed port site recurrence in endometrial and cervical carci-
nomas with two patients each. While none of the 10 women with
metastatic ovarian cancer developed such recurrence, vagina vault
recurrence were also not observed even though malignant disease
was extracted through the vagina in many cases. All recurrences
were associated with abdominopelvic and or distant metastasis
and all occurred at untreated trocar sites. He concluded that port
site recurrences are local manifestations of disseminated disease
that results from enhancement of tumor growth characteristics of
healing tissues and can be prevented by appropriate postoperative
therapy.
In our study, all port site recurrences were associated with
disease at other local sites; isolated port site recurrences were not
found. Vaginal vault recurrence was also seen when the specimen
was extracted through the vagina and most of the patients had
pelvic recurrence. These ﬁndings were consistent with observa-
tions done in laparoscopic resections of colorectal malignancies
which showed that 50% abdominal wall recurrence occur at the
tumor extraction site.19e31
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taken during surgery by avoiding rupture of cyst, avoiding spillage
of contents, handling of the specimen, taking out the specimen in
an endobag, and full thickness closure of port sites and post-
operative therapy.Conclusion
Port site recurrence in laparoscopic gynecological malignant
surgeries occur because of the immense complexity of the proce-
dure and problems of preferring an adequate surgery. Furthermore,
port site metastasis were not lone sites of recurrence and were
associated with local recurrence of disease. But unlike other port
recurrences, vault recurrence poses great difﬁculty in management
and results in greater morbidity, as well as considerably reducing
the chance of survival.References
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